These findings have largely been explained by the higher reductive 17β‐hydroxysteroid dehydrogenase activity and expression of aldo‐keto reductase type 1C3 (AKR1C3) in obese individuals as well as in women with PCOS [20, 21]. This evidence concerns the gene AKR1C3 and polycystic ovary syndrome.